Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.667, 2012-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pneumococcal conjugate vaccine potentially cost saving in the US
Inpharma, Vol. 1, Iss. 1230, 2000-01 ,pp. :
Galantamine potentially cost saving for AD in Sweden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 376, 2002-01 ,pp. :
Pertussis vaccination potentially cost saving in Germany
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 558, 2008-01 ,pp. :
Telithromycin potentially cost saving in patients with AECB
Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. :
Galantamine potentially cost saving for AD in Sweden
Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. :